In a ground breaking advancement poised to revolutionize the fields of vaccinology and nanomedicine, researchers have developed a novel binary self-amplifying expression platform capable of producing vaccines and nanomedicines without the need for lipid nanoparticles (LNPs). This innovative technology, published in the prestigious journal Nature Communications in 2025, could herald an era of safer, more efficient, and scalable vaccine production by circumventing several limitations associated with current lipid nanoparticle-based delivery systems. Read More
In October 2025, Dr. James (Jim) Zimring joined Canadian Blood Services’ I&PM team as our chief science officer. In this role, Dr. Zimring will provide leadership for the teams of discovery, development, donation policy and studies, and medical microbiology researchers and staff whose efforts support our vision to help every patient, match every need and serve every Canadian. An established scientist himself, Dr. Zimring also continues to undertake discovery research in his lab located at the Centre for Blood Research, University of British Columbia (UBC) in Vancouver. Read More
Dr. Sarah Hedtrich and her team examine a skin-on-a-chip model used to test the new CRISPR-based therapy on living human skin samples. Read More
This past year, the CBR was pleased to support 6 award recipients, who attended and presented at conferences and workshops held around the globe. Following their conference attendance, recipients shared their experiences through short reflection blogs on the CBR website, which reflect their educational experiences and key takeaways. Read More
Mahsa Yazdanbakhsh shares her experience in the Earl W. Davie Symposium 2025. Read More
CBR/LSI Summer Studentship Program Application Form
Learn more about the CBR/LSI Research Day here!
Learn about recent research, awards, blogs and stories about the CBR. Read more.
Join us on Wednesdays to attend our CBR Seminars! See upcoming seminars here.
